Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance
Doctors can diagnose pneumonia, but cannot easily identify the underlying microorganism
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050
Our Team
Jordan Parker
Position / Role
Max Johnson
Position / Role
Drew Carlyle
Position / Role
Morgan James
Position / Role
Any sample works
Compatible with respiratory swab, blood, urine, saliva, stool…
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value < $10,000, consumables < $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test
We are developing a quantitative analysis capable of detecting all microrganisms in both clinical and non-clinical samples, using a fast and cheap technology which can be deployed at the point of care.
Giulio Deangeli
↗
2024 - Final year PhD candidate, University of Cambridge
2021 - «100 number ones» by Forbes
2020 - 5 university courses in parallel, 30/30 GPA
2018 - Harvard HIP Scholarship, ranked in top 5%
2016 - Amgen Scholarship, Cambridge, ranked #1
2013 - World Vice-Champion Neuroscience, IBB
Author of 2 books; papers in Science, Cell and Brain
MD, PhDc, MBiotech, MMedSci, BEng
Cristiano Peron
↗
2023 - PhD, University of Oxford
2023 - Clinical Fellow Oxford University Hospital
2021 - Old Silver VC Fellow, Boston
2019 - Medical Doctor, summa cum laude
2018 - Armenise-Harvard Fellowship, Harvard University
2017 - IEF Fellowship, Columbia university
Author of papers in Cell and other peer reviewed journals
MD, PhD
Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral
Doctors can diagnose
pneumonia, but cannot
easily identify the underlying
microorganism
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
Doctors can diagnose
pneumonia, but cannot
easily identify the underlying
microorganism
By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral
Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)
Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide
Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050
Any sample works
Compatible with respiratory swab, blood, urine, saliva, stool…
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value
< $10,000, consumables
< $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test
Point of care
Can sit on a desk, no lab required
Fast
Result in 10-15 minutes
Cheap
Device intrinsic value
< $10,000, consumables
< $50 /test
Quantitative
Customizable panel of 50+ viruses, bacteria, and fungi in 1 test
Giulio Deangeli
↗
2024 - Final year PhD candidate, University of Cambridge
2021 - «100 number ones» by Forbes
2020 - 5 university courses in parallel, 30/30 GPA
2018 - Harvard HIP Scholarship, ranked in top 5%
2016 - Amgen Scholarship, Cambridge, ranked #1
2013 - World Vice-Champion Neuroscience, IBB
Author of 2 books; papers in Science, Cell and Brain
MD, PhDc, MBiotech, MMedSci, BEng
Cristiano Peron
↗
2023 - PhD, University of Oxford
2023 - Clinical Fellow Oxford University Hospital
2021 - Old Silver VC Fellow, Boston
2019 - Medical Doctor, summa cum laude
2018 - Armenise-Harvard Fellowship, Harvard University
2017 - IEF Fellowship, Columbia university
Author of papers in Cell and other peer reviewed journals
MD, PhD